UBS Contributes Blockchain Code to HIV Research Effort

UBS has donated the code for a blockchain-based trading platform to a nonprofit group funding research into a cure for HIV/AIDS.

AccessTimeIconJan 22, 2016 at 1:00 a.m. UTC
Updated Sep 11, 2021 at 12:06 p.m. UTC

UBS has donated the code for a blockchain-based trading platform to a nonprofit group funding research into a cure for HIV/AIDS.

The HEAL Alliance, a nonprofit group focused on supporting HIV research, plans to use UBS's code as part of a platform being developed by London-based financial tech startup Finclusion Systems, with the goal being to ultimately raise money using the technology.

The UBS Innovation Lab is one of the backers of the initiative alongside Microsoft, Intel, and the University of California San Francisco­ Gladstone Institute of Virology and Immunology Center for AIDS Research.

UBS donated code to the initiative previously developed for use in a proposed blockchain-based trade settlement system. The bank was one of several firms tied to the initiative, a group that also includes the CME Group, Euroclear, LCH.Clearnet, the London Stock Exchange and Société Générale.

The HEAL Alliance is hoping to raise $10bn selling 'social impact bonds' on the blockchain-based platform, which is currently undergoing testing and not collecting investments at this time.

Funds raised will be used to foster research into a cure for the autoimmune disease.

When reached for comment, UBS Group chief information officer Oliver Bussmann said that the initiative grows out of a previous effort to create programmable bonds using blockchain technology.

"This experiment confirmed the potential benefits: clearing and settlement on blockchain could be faster, more efficient and transparent while reducing settlement risk and operational cost," he said.

Bussmann continued:

"UBS is proud to contribute to the HEAL Bond on Blockchain and agreed to share the learnings of its 'Smart Bond' experiment with the HEAL Alliance.”

Pixeljoy / via Shutterstock


Please note that our privacy policy, terms of use, cookies, and do not sell my personal information has been updated.

The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.

Learn more about Consensus 2024, CoinDesk’s longest-running and most influential event that brings together all sides of crypto, blockchain and Web3. Head to to register and buy your pass now.